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Abstract
Background: Staphylococcus aureus and Coagulase-negative staphylococci (CoNS) are a major source of infections
associated with indwelling medical devices. Many antiseptic agents are used in hygienic handwash to prevent
nosocomial infections by Staphylococci. Our aim was to determine the antibiotic susceptibility and resistance to
quaternary ammonium compound of 46 S. aureus strains and 71 CoNS.
Methods: S. aureus (n = 46) isolated from auricular infection and CoNS (n = 71), 22 of the strains isolated from
dialysis fluids and 49 of the strains isolated from needles cultures were investigated. Erythromycin resistance genes
(ermA, ermB, ermC, msrA and mef) were analysed by multiplex PCR and disinfectant-resistant genes (qacA, qacB,
and qacC) were studied by PCR-RFLP.
Results: The frequency of erythromycin resistance genes in S. aureus was: ermA+ 7.7%, ermB+ 13.7%, ermC+ 6%
and msrA+ 10.2%. In addition, the number of positive isolates in CoNS was respectively ermA+ (9.4%), ermB+
(11.1%), ermC+ (27.4%), and msrA+ (41%). The MIC analyses revealed that 88 isolates (74%) were resistant to
quaternary ammonium compound-based disinfectant benzalkonium chloride (BC). 56% of the BC-resistant
staphylococcus isolates have at least one of the three resistant disinfectants genes (qacA, qacB and qacC). Nine
strains (7.7%) among the CoNS species and two S. aureus strains (2%) harboured the three-qac genes. In addition,
the qacC were detected in 41 strains.
Conclusions: Multi-resistant strains towards macrolide and disinfectant were recorded. The investigation of
antibiotics and antiseptic-resistant CoNS may provide crucial information on the control of nosocomial infections.
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Background
The increasing number of infections caused by oxacillin-
resistant staphylococci makes glycopeptide antibiotics an
important choice [1]. The significant prevalence of noso-
comial infections caused by multi-resistant S. aureus and
coagulase-negative staphylococci (CoNS) has been docu-
mented [2,3]. These species have the ability to survive in
medical devices for months [4]. Resistance to erythro-
mycin in staphylococci is usually associated with resis-
tance to other macrolides. Three genes (ermA, ermB,
and ermC) encoding methyltransferases responsible of
resistance to macrolides, lincosamides and type B
streptogramins (MLSB phenotype) by modification of
the ribosomal target site have been found in staphylo-
cocci [5]. The msrA gene displays another mechanism
of inducible resistance to erythromycin by encoding an
ATP-dependent efflux pump [6]. On the other hand,
m a c r o l i d ee f f l u xi sa f f e c t e db yam e m b r a n ep r o t e i n
encoded by the mef gene [7]. Antiseptic agents include
various compounds with different chemical structures
[8]. The widespread use of quaternary ammonium com-
pounds (QAC) in hospitals actually contributes to the
emergence of disinfectant-resistant bacteria [9,10].
Epidemiological data on antiseptic susceptibility and the
distribution of resistance genes are both useful for noso-
comial infection control. In several staphylococcal spe-
cies, qac-resistant genes have been identified [11-13].
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these genes are generally carried by plasmids [14-16].
Some of these plasmids (pST6, pSK4, and pSK41) con-
tain antibiotic resistance genes encoding resistance to
gentamicin, penicillin, kanamycin, and tobramycine
[17,18]. Multidrug resistance pumps have been recog-
nized as mediators of a number of commonly used
ammonium antiseptics and detergents [19]. The nearly
identical qacA/B gene is normally harboured by large
plasmids [20,21]. The relation between qac resistance
and penicillin resistance in human clinical staphylococci
is quite prevalent [22].
In the present study, we examined the antibiotic sus-
ceptibility and resistance to quaternary ammonium com-
pound-based disinfectant benzalkonium chloride (BC) of
46 S. aureus strains isolated from auricular infection and
71 CoNS isolated from dialysis fluids and needles cul-
tures. In order to examine the genetic drug resistance
mechanisms, erythromycin resistance genes (ermA,
ermB, and ermC) and macrolide efflux genes (msrAa n d
mef) were analysed by PCR multiplex. In addition, qua-
ternary ammonium resistance genes (qacA, qacB, and
qacC) were detected by PCR-RFLP.
Methods
Biochemical characterization and antimicrobial
susceptibility
A total of 117 clinical staphylococcal strains were isolated
from Kairouan, in central of Tunisia including 46 S. aureus
strains isolated from auricular infection and 71 CoNS
strains isolated from dialysis fluid and needles from a dia-
lysis service. All strains were identified using the Api ID32
Staph system (bioMérieux, Marcy l’Étoile, France) accord-
ing to the manufacturer’s recommendations and the
results were read using an automated microbiological
mini-Api (bioMérieux, Marcy l’Étoile, France). Each strain
was tested for 18 antibiotics (penicillin, oxacillin, kanamy-
cin, tobramycin, gentamicin, tetracycline, minocyclin, ery-
thromycin, lincomycin, pristinamycin, fosfomycin,
nitrofurantoin, pefloxacin, rifampicin, fusidic acid, vanco-
mycin, teicoplanin and cotrimoxazol) using the ATB
Staph system (bioMérieux, France) according to the man-
ufacturer’s specifications.
Minimum inhibitory concentration determination
The broth microdilution method was used to determine
the minimum inhibitory concentration (MIC) of benzal-
chonium chloride (BC) (Acros organics, USA) (ranging
from 0.5 to 256 μg/ml, by serial twofold dilutions) against
the tested strains as recommended by the Clinical and
Laboratory Standards Institute (CLSI) [23]. An inoculum
of 10
4 -10
5 cells ml
-1 was used. The lowest concentration
of antimicrobial agent totally preventing growth after 24 h
was taken to be the MIC.
Multiplex PCR for the detection of macrolide-resistance
encoding genes
Macrolide resistance genes ermA, ermB, ermC, msrA, and
mef were examined in all strains using multiplex PCR, as
previously described [24,25]. Multiplex PCR assays were
performed in 25 μl PCR mixture 1 and mixture 2.
Mixture 1 contained a DNA template (50 ng), 100 μM
concentrations (each) of the four dNTPs, 1 U of Go Taq
DNA polymerase (Promega, Lyon, France), 5 μLg r e e n
Go Taq buffer (5X), 25 pM each of forward and reverse
primers ermA, ermC, and msrA (Table 1). The PCR mix-
tures were subjected to thermal cycling (3 min at 96°C,
followed by 30 cycles of 30 sec at 95°C for denaturation,
30 sec at 55°C for annealing extension, and extension at
72°C for 2 min). A final elongation at 72°C for 10 min
was achieved in a DNA thermal cycler (GenAmp PCR
system 9700-Applied Biosystem Int., USA). For mixture
2, the forward and reverse primers (25 pM) of genes
ermBa n dmef were used. PCR products were analysed in
agarose gel (1%) electrophoresis in 1X Tris-borate-EDTA
buffer (TBE) at pH 8.3. The amplification products were
photographed and their size was determined using a
100 bp molecular size marker (Bio-Rad, France).
Detection of qacA, qacB, and qacC genes by PCR-RFLP
Multiplex PCR-RFLP analysis of the qacA/B and qacC
genes was achieved as described by Sekiguchi et al. [26].
For the fragment qacA/qacB, the forward primer (corre-
sponding to nucleotides 924-946) and the reverse primer
(corresponding to nucleotides 1143-1124) produced 220
bp. For the qacC gene, the forward primer (nucleotides
73-97) and the reverse primer (nucleotides 321-302) pro-
duced 249 bp. PCR was performed in a 25 μl reaction
volume containing 50 ng of extracted DNA, 5 μlg r e e n
Go Taq buffer (5X), 200 μM each of deoxynucleoside tri-
phosphates (dNTP), 25 μM each of qacA, qacB, and
qacC forward and reverse primers, 1 U of GO Taq DNA
polymerase (Promega, USA). Each PCR was performed in
duplicate. The reaction mixtures were heated to 94°C for
5 min and were then subjected to 30 denaturation cycles
at 94°C for 1.5 min, annealing at 56°C for 0.5 min and
extension at 72°C for 1.5 min, ending with a final exten-
sion at 72°C for 10 min.
Following PCR, the product was digested with 5 U of
AluI at 37°C for 90 min (Promega, France). Ten microli-
tres of treated product were analysed by gel electrophor-
esis in 3% agarose gel in 1X Tris-borate-EDTA buffer
(TBE, pH 8.3). The amplification products were photo-
graphed and their size was determined using a 25 bp
molecular size marker (Promega, USA). The qacBg e n e
was expected to be digested into two fragments: a visible
176 bp fragment and another fragment of 44 bp which
is invisible. QacAa n dqacC genes were not expected to
be digested [26].
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Statistical analysis was performed on SPSS v.13.0 statis-
tics software. Pearson’sc h i - s q u a r e
-2 test was used to
asses inter-group significance. In addition statistical sig-
nificance was set at P < 0.05.
Results
Biotyping and antimicrobial susceptibility
In this study, 46 S. aureus strains isolated from auricular
infection were identified. In addition 71 CoNS were iso-
lated and were subdivided into eight species: S. epidermi-
dis (n = 32) (45%) followed by S. hominis (n = 10) (14.1%),
S. haemolyticus (n = 9) (12.7%), S. warneri (n = 5) (7%),
S. simulans (n = 6) (8.5%), S. capitis (n = 4) (5.6%), S. chro-
mogenes (n = 3) (4.2%), and S. equorum (n = 2) (2.8%).
The results of the antibiotic susceptibility test con-
firmed the multi-resistance of 117 staphylococcal strains
toward the 18 antibiotics mentioned previously. The
majority of these strains were resistant to penicillin
(91.1%). The isolated strains were also resistant to kana-
mycin (45.7%), tetracycline (47.8%), erythromycin
(37.7%), lincomycin (21.2%), fosfomycin (20.8%), fusidic
acid (17.3%), pefloxacin (18.4%), cotrimoxazol (24.3%),
teicoplanin (10.5%), gentamicin (13.4%), rifampicin
(12.1%), and tobraycin (16.8%).
Oxacillin-resistant phenotype was found in 9 S. aureus
(7.7%) and 24 CoNS (20.5%) isolated strains. All of the
strains were susceptible to pristinamycin, nitrofurantoin,
and vancomycin (Table 2 and 3).
Resistance to disinfectants agents
The 117 staphylococcus isolates were screened for QAC
(BC) resistance. The strains were categorized as BC
resistant or sensitive according to the BC MICs. Twenty
four (20%) isolates were considered BC highly resistant
(BC MICs between 16 and 32 μg/ml), 64 (54%) isolates
were resistant to BC (BC MICs between 4 and 8 μg/ml),
and 28 (23%) strains were sensitive to BC (BC MICs ≤ 2
μg/ml). 117 staphylococci isolates were analyzed for cor-
relation between BC and antibiotic resistance (Figure 1).
This analysis showed that the frequency of erythromycin
resistance 71% and oxacillin resistance 84% was higher
among the BC-resistant strains.
Multiplex PCR for the detection of genes encoding
macrolide resistance
In this study we found that the incidence of the three ery-
thromycin ribosomal methylase genes tested was 9 (7.7%)
strains of S. aureus contained ermA, 16 (13.7%) strains
harbored ermB gene and 7 (6%) strains were positive for
ermC in the total of 117 isolated strains (Figure 2A, B).
Furthermore among the CoNS 11 (9.4%) strains contained
ermA. In addition, on the total of 117 isolated strains 13
CoNS strains carried the ermB gene, while 32 (27.3%)
were positive for ermC. The msrA gene was present in 12
(10.2%) of S. aureus strains and in 48 (41%) CoNS strains
(Figure 2A). In contrast, the mef gene was absent in all the
staphylococcal strains tested. Sixteen strains of S. epider-
midis,e i g h ts t r a i n so fS. aureus and eighteen strains of
CoNS were positive for the mecA gene, yet were suscepti-
ble to oxacillin. Furthermore, only nine strains of CoNS
(7.7%) and nineteen strains (16.2%) of S. aureus were sus-
ceptible to erythromycin, those isolated did not contain
any of the erythromycin-resistance genes tested. However,
in five S. epidermidis strains (E7, E20, S23, S27, and S40),
and in ten S. aureus stains, the ermAa n dermCg e n e s
were not detected, although it was resistant to erythromy-
cin (Table 2 and 3).
PCR-RFLP detection of qacA, qacB, and qacC genes
Among the tested S. aureus two strains (Sa22 and Sa23)
carried the three qac genes (qacA, qacBa n dqacC)
Table 1 List of primer used for the detection of genes encoding antibiotics and quaternary ammonium compound
resistance
Gene Primer 5’-3’ Product Size pb Reference
ermA5 ’-TAT CTT ATC GTT GAG AAG GGA TT-3’
5’-CTA CAC TTG GCT TAG GAT GAA A-3’
139 [22]
ermB5 ’-CTA TCT GAT TGT TGA AGA AGG ATT-3’
5’-GTT TAC TCT TGG TTT AGG ATG AAA-3’
142 [22]
ermC5 ’-CTT GTT GAT CAC GAT AAT TTC C-3’
5’-ATC TTT TAG CAA ACC CGT ATT C-3’
190 [22]
msrA5 ’-TCC AAT CAT AGC ACA AAA TC-3’
5’-AAT TCC CTC TAT TTG GTG GT-3’
163 [22]
mef 5’-AGTATCATTAATCACTAGTGC-3’
5’-TTCTTCTGGTACAAAAGTGG-3’
348 [23]
qacA, qacB5 ’-TCCTTTTAATGCTGGCTTATACC-3’
5’-AGCCKTACCTGCTCCAACTA-3’
220 [24]
qacC5 ’-GGCTTTTCAAAATTTATACCATCCT-3’
5’-ATGCGATGTTCCGAAAATGT-3’
249 [24]
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Samples qacA qacB qacCB C
b mecA ermA ermB ermC msrA Antibiotic
S. epidermidis E10 + - + 16 + - + + + Oxa
S, Ery
S
E11 - - + 8 + - + + + Oxa
R
E13 - - - 4 - - - - - Oxa
R
E15 - - + 8 + - + + - Oxa
R, Ery
R
E18 + - + 16 + - - + + Oxa
S, Ery
S
E20 - - - 2 + - - - + Ery
R
E21 + - + 8 + - - + + Oxa
R
E24 - - - 8 + - - + + Ery
R
E4 - - - 4 - - - - - Oxa
R
E5 - - - 4 - - - - - Oxa
R
E6 - - - 2 + - + + + Oxa
S, Ery
S
E7 - - + 8 - - - - - Ery
R
E9 - - + 16 + - + - + Oxa
S, Ery
S
S12 - - + 16 - - - - + Oxa
S, Ery
S
S15 - - + 8 + + + + + Oxa
R, Ery
R
S16 - - + 8 + - + + + Oxa
S, Ery
S
S2 - - + 8 + - - + + Oxa
S, Ery
S
S21 + + + 32 + + - + + Oxa
R
S22 - - - 8 + - - + + Oxa
S, Ery
S
S23 - - - 2 + - - - + Ery
R
S25 - - + 8 + - + + + Oxa
R
S26 - - + 4 + - + + + Oxa
R, Ery
R
S27 - - - 2 - - - - + Ery
R
S33 - - - 2 + + - - - Oxa
S, Ery
S
S35 - - - 2 - - - - - Oxa
S, Ery
S
S38 - - - 4 + - - - - Oxa
S, Ery
S
S40 - - + 8 + - - - + Oxa
R, Ery
R
S43 - - - 2 + - - - + Oxa
S, Ery
S
S48 - - - 2 + + - + - Oxa
R, Ery
R
S56 - - - 2 + - + + + Oxa
R, Ery
R
S59 - - - 4 + - - - - Oxa
S, Ery
S
S9 + + + 16 + - - + + Oxa
S, Ery
S
S. hominis E17 - - - 16 + - - + - Oxa
R
E2 - - - 2 - - - - - Oxa
S, Ery
S
E27 - - - 2 - - - - + Oxa
S, Ery
S
S18 + + + 16 - + - + + Oxa
S, Ery
S
S3 - - + 8 + - - + - Oxa
R, Ery
R
S45 + - - 4 + - - - - Oxa
R, Ery
R
S50 - - - 4 + - - - + Ery
R
S53 - - - 2 + - - - + Ery
R
S54 - - - 2 - - - - - Ery
R
S57 + - + 8 + - - + - Oxa
R
S. equorum E3 + - + 8 + - - - + Ery
R
S6 + + + 16 + - + + + Oxa
R, Ery
R
S. capitis E25 + + + 32 - + - + + Oxa
S, Ery
S
S1 + + - 32 + + - - + Oxa
S, Ery
S
S34 + - + 32 - - - - + Ery
R
S49 - - - 8 + - - - + Oxa
S, Ery
S
S. hemolyticus E16 - - + 8 + - - - + Ery
R
E19 + + + 16 + - - - + Ery
R
E22 - - + 8 + - - - + Ery
R
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S10 - - - 4 + - - - + Oxa
R, Ery
R
S13 + + - 8 + - - - + Oxa
S, Ery
S
S24 + + + 16 + - - - + Ery
R
S39 + - + 16 + + - + - Oxa
R, Ery
R
S42 + - + 16 + - + - + Oxa
R, Ery
R
S8 - - - 8 + - - - - Oxa
R, Ery
R
+, presence of the gene -, absence of the gene; Oxa
R, oxacillin resistance; Oxa
S, oxacillin susceptible; BC
b , MIC of benzalchonium chloride μg/ml.
Table 3 Distribution of disinfectant and macrolide resistance genes in staphylococci
Species Samples qacA qacB qacCB C
b mecA ermA ermB ermC msrA Antibiotic
S. warnerie S11 - - + 8 + - - + + Oxa
S, Ery
S
S14 - - - 2 - - - - + Oxa
S, Ery
S
S29 - + - 8 - - - - + Oxa
S, Ery
S
S37 - - + 8 + - - + + Oxa
S, Ery
S
S47 - + - 4 + + + + + Oxa
S, Ery
S
S. chromogene S30 + - + 16 + - - + + Ery
R
S32 - - - 2 - - - - + Oxa
S, Ery
S
S51 - - - 2 - - - - - Ery
R
S. simulans E23 - - + 4 + + - + - Ery
R
S19 + - + 16 + - - + - Oxa
R, Ery
R
S20 - - - 4 + - - - + Oxa
S, Ery
S
S28 + + + 32 + + - + + Oxa
R, Ery
R
S36 + - - 8 + - - - - Oxa
S, Ery
S
S5 + + + 16 + - - + - Oxa
R
S.aureus Sa1 --+ 8 + + + - - Oxa
R, Ery
R
Sa2 --- 4 - - - - - Oxa
S, Ery
S
Sa3 --- 8 - - + - - Oxa
S, Ery
S
Sa4 --- 4 - - - - - Oxa
S, Ery
S
Sa5 ++- 8 - + - + + Oxa
S, Ery
S
Sa6 --- 8 - - - - - Oxa
S, Ery
S
Sa7 --- 4 - - - - - Oxa
S, Ery
S
Sa8 --- 8 + - + - + Oxa
R, Ery
R
Sa9 --- 2 - - - + - Oxa
S, Ery
S
Sa10 ++- 8 + - + - - Ery
R
Sa11 --- 4 + - + - + Ery
R
Sa12 --- 8 + - + - + Ery
R
Sa13 --- 8 + - + - - Oxa
S, Ery
S
Sa14 --- 4 + - - - - Oxa
R
Sa15 --- 8 + + + + + Oxa
S, Ery
S
Sa16 --- 4 + - - - - Oxa
R
Sa17 --- 2 - - - - + Ery
R
Sa18 --- 2 - + + - - Oxa
S, Ery
S
Sa19 + - + 8 - - + - - Oxa
S, Ery
S
Sa20 + -+ 4 - + + + + Oxa
S, Ery
S
Sa21 --- 16 - - + - - Oxa
S, Ery
S
Sa22 +++ 16 + - - + - Oxa
R, Ery
R,
Sa23 +++ 16 + + + + + Oxa
R, Ery
R
Sa24 --- 4 - - - - - Ery
R
Sa25 --- 4 - - - - - Oxa
S, Ery
S
Sa26 --- 4 + - - - + Oxa
R, Ery
R
Sa27 --- 2 + + - - + Oxa
R, Ery
R
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three qac genes (qacA, qacBa n dqacC). In addition,
qacC was the most present (35%), followed by qacA
(24%), and qacB (15.4%) in the total of 117 isolated
strains (Table 2 and 3).
Qac-resistant genes (qacA) were identified in (5.12%)
followed by qacC (4.27%) and qacB (3.41%) in the isolated
S. aureus strains, while 39 (33%) strains were qac-negative
in the total of 117 isolated strains (Figure 4.). On the other
hand, among the 32 S. epidermidis strains under study,
five were qacA+, two were qacB+, and 16 were qacC+,
while 29 strains were qac-negative (Table 2 and 3). The
three Qac-resistant genes (qacA, qacB, and qacC) were
identified in 9.4% of the total isolated strains. Nine strains
(7.7%) of six different CoNS species harboured the three
qac-resistant genes.
Discussion
Recently, the increasing numbers of device-related infec-
tions associated with methicillin-resistant staphylococci
have raised awareness toward the need for alternative
agents to prevent these infections. S. epidermidis species
represent the CoNS most recovered from clinical speci-
mens [3]. Among the 71 CoNS isolated in this study, the
most prevalent were S. epidermidis (n = 32), S. hominis
(n = 10), and S. haemolyticus (n = 9). The antibiotic sus-
ceptibility of the 117 staphylococal (S.aureus and CoNS)
isolated in this study confirmed the multi-resistance of
these strains toward the 18 antibiotics cited previously.
Oxacillin resistance occurred in 7.7% of S. aureus and in
20.5% of CoNS tested by ATB Staph.
Erythromycin resistance in staphylococci is predomi-
nantly mediated by erythromycin-resistant methylase
encoded by erm genes [27]. The inducible gene ermA is
found on the transposon Tn554 and has a single specific
site for insertion into the S. aureus chromosome [28]. The
ermB gene is found on the transposon Tn551 of a penicil-
linase plasmid [29]. The ermC gene is responsible for con-
stitutive or inducible resistance to erythromycin and is
generally located on small plasmids [5,27,30]. On the
other hand, the investigation of the prevalence of ermA,
ermB, ermCa n dmsrA genes in Staphylococci showed that
only 28 strains of S. aureus (n = 46) and CoNS (n = 71)
were found to be susceptible to erythromycin, yet con-
tained erythromycin-resistant gene, and 44 strains (13 S.
aureus and 31 CoNS) have at least one of the four genes
(ermA, ermB, ermC and msrA) and were susceptible to
erythromycin. Similarly, Sekiguchi et al. [26] found discor-
dance among phenotypic susceptibility and the presence
of erm genes. They stated that this discordance might be
Table 3 Distribution of disinfectant and macrolide resistance genes in staphylococci (Continued)
Sa28 --- 2 + - - - - Ery
R
Sa29 --- 2 + - - - - Oxa
S, Ery
S
Sa30 --- 8 + + + - - Oxa
S, Ery
S
Sa31 --- 2 + - + - - Ery
R
Sa32 --- 2 + - + - - Oxa
R
Sa33 --- 4 + - - - - Ery
R
Sa34 --- 8 + - - - - Oxa
S, Ery
S
Sa35 --- 4 + - - - - Oxa
S, Ery
S
Sa36 --- 2 - + - + + Oxa
S, Ery
S
Sa37,
Sa38
Sa43,
Sa44
Sa45
--- 8
2
8
8
2
- - - - - Oxa
S, Ery
S
Sa39,
Sa42
Sa41,
Sa40
--- 8
16
2
8
+ - - - - Oxa
S, Ery
S
Sa46 --- 2 + - - - + Oxa
S, Ery
S
+, presence of the gene -, absence of the gene; Oxa
R, oxacillin resistance; Oxa
S, oxacillin susceptible; BC
b, MIC of benzalchonium chloride μg/ml.
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Figure 1 Percentages of antibiotic-resistance Staphylococci
isolates among BC-resistance and BC-sensitive isolates.
Antibiotics used are erythromycin (ERY) and oxacillin (OXA).
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PCR-detected genes. We noted also that eight strains of S.
aureus and CoNS strains were found to be resistant to ery-
thromycin but did not carry any erythromycin resistance
gene (Table 1 and 2). This result may be explained by the
location of these genes in small plasmids, which were
occasionally lost. Fluit et al. [31] demonstrated that the
ermC gene responsible for erythromycin resistance is
located on a small plasmid. In this study, the incidences of
ermA in erythromycin-resistant staphylococci were 7.7%
for S. aureus and 3.4% for S. epidermidis. These findings
are in disagreement with the study by Eady et al. [5] con-
ducted with coagulase-negative staphylococci (CoNS) in
the United Kingdom in which an incidence of 5.9% for
ermA was reported. In a study performed in Denmark,
16% of S. aureus strains were carrying ermA, while only
3% of CoNS strains had this gene [30]. Regarding ermB,
we found that this gene was more frequently encountered
than ermA in erythromycin-resistant staphylococci with
24.8% (13.7% for S.aureus and 11% for CoNS) of total
strains carrying ermB. In the United Kingdom, an inci-
dence of 7.2% for ermB in CoNS has been reported [5].
Staphylococcal strains resistant to macrolides and type-B
streptogramins frequently harbour msrA, which encodes
an ATP-dependent efflux pump [5]. Erythromycin resis-
tance may be caused by the msrAo rermB gene, as pre-
viously reported with staphylococci [5]. Our results are
similar to those of a recent study investigating a high level
of ermAa n dermC genes in CoNS [32].
Staphylococcal multidrug-resistant gene qacAi sg e n -
erally mediated by plasmids mediated resistance to var-
ious toxic organic cations and ethidium bromide, as well
142 bp
(B) 
 1      2       3      4  1    2   3   4    5   6    7   8   9  10  11  12 13     
190 bp 
139 bp 
163 bp 
300 bp 
200 bp 
100 bp 
(A) 
Figure 2 (A) PCR analysis of erythromycin-resistant determinants: ermA (139 bp), msrA (163 bp) and ermC (190 bp) with clinical
strains; source of DNA: 1: 100 bp DNA molecular size marker; 2: negative control; 3: S16; 4: E6; 5: E18; 6: S40; 7: E24; 8: E20; 9: S22;
10: S12; 11: S9; 12: S21 and 13: E15. (B) Agarose gel electrophoresis of PCR amplicon of erythromycin-resistant ermB gene (142 bp) obtained
with DNA of clinical strains; 1: 100 bp DNA molecular size marker; 2: negative control; 3: E10 and 4: E11.
250 bp 
175 bp 
50 bp 
25bp 
249 bp 
220 bp 
 174 bp
 1      2       3       4       5       6       7       8        9     10 
Figure 3 PCR-RFLP analysis for the detection of qacA (220 bp),
qacB (174 bp), and qacC (249 bp) genes in S.aureus;1 :2 5b p
DNA molecular size marker; 2: negative control; 3: Sa1; 4: Sa5;
5: Sa10; 6: Sa13; 7: Sa19; 8: Sa20; 9: Sa22 and 10: Sa23.
249 bp
220 bp
174 bp
25 bp 
   1        2        3      4       5       6       7       8        9     10     11     12     13    
100 bp 
175 bp 
250 bp 
Figure 4 PCR-RFLP analysis for the detection of qacA (220 bp),
qacB (174 bp), and qacC (249 bp) in CoNS; 1: 25 bp DNA
molecular size marker; 2: negative control; 3: S9; 4: E15; 5: E13;
6: E6; 7: S18; 8: E7; 9: S13; 10: S19; 11: S11; 12: S45 and 13: S39.
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Page 7 of 9as a number of commonly used antiseptics and disinfec-
tants, such as benzalkonium chloride and chlorhexidine
[19]. The qacA gene also encodes resistance to both
monovalent and divalent organic cations. In addition,
qacB characteristically differs from qacAb yc o n f e r r i n g
lower or no resistance to divalent organic cations [33].
Some investigations have implied that there is disinfec-
tant cross-resistance with antibiotics [34,35].
Among the tested bacteria, 2 strains of S.aureus and 9
strains of CoNS carried the three qac genes (qacA, qacB,
and qacC), as shown in Table 1 and 2. QacC gene was the
most present in the 117 isolated strains (35%), followed by
qacA( 2 4 % ) ,a n dqacB (15. 4%). Of the 117 isolates investi-
gated in this study, 74% were phenotypically resistant to
BC. 56% of the BC-resistant staphylococcus isolates have
at least one of the three resistant disinfectants genes
(qacA/B and qacC). Previous investigators have reported a
similar distribution of these three qac resistance genes in
clinical S. aureus and CoNS [36,15]. Little is known about
the occurrence and possible genetic linkage of qac and
antibiotic resistance in staphylococci. Interestingly, we
observed that staphylococci resistant to BC were generally
more often resistant to antibiotics (Ery and Oxa) than BC-
sensitive isolates (Figure 1).
Furthermore, among the nine MRSA isolates, two
strains (Sa22 and Sa23) were multi-resistant to antibiotic
and harboured the qac genes. MRSA isolates resistant to
antiseptics and disinfectants have been reported in Aus-
tralia and in United Kingdom in the last decade [8]. Seki-
guchi et al., [26] have found that among the 65 MRSA
isolates 32 (49.23%) were positive for qacA, while one
isolate was positive for qacB and seven MRSA 10% were
positive for qacC. Three strains of S. hemolyticus har-
boured qacAa n dqacB genes. In a recent study, S. hemo-
lyticus isolates were shown to contain both qacAa n d
qacB genes [37]. QacA/B genes are typically located on a
transposon of transmissible multidrug-resistant plasmids,
such as pSK1 [33]. Staphylococci resistant genes to qua-
ternary ammonium compounds (QACs) have been
detected in clinical coagulase-negative staphylococci [36].
QAC resistant Staphylococcus spp. hosting qacA/qacB
and smr have been isolated from different environments
[38]. Results from a recent study in Norway suggest that
qac-resistant genes are common in human clinical sta-
phylococci and that a direct link between resistance to
QACs and resistance to penicillin occurs in clinical iso-
l a t e so fh u m a na n da n i m a lo r i g i na sw e l la si nf o o d -
related staphylococci [11,22]. Noguchi et al. [16] reported
that when the antiseptic susceptibility and the distribu-
tion of antiseptic-resistant genes of MRSA isolated in
Japan in 1992 were studied, qacA/B were detected in
10.2% (10/98). However, seven years later, qacA/B genes
were detected in 47.9% (198/413) in MRSA isolates in
Japan.
Conclusion
It appears that the widespread distribution of staphylo-
cocci carrying macrolides and qac-resistant genes found in
dialysis biomaterial collected in Tunisia may be due to the
transfer of resistance plasmids among species and strains,
thereby contributing to the dissemination of staphylococ-
cal resistance. Therefore, a closer investigation of antibio-
tics and antiseptic-resistant CoNS may provide crucial
information on the control of nosocomial infections.
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